Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07701083 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Eloralintide (LY3841136) in Healthy Participants

Name: A Study of Eloralintide (LY3841136) in Healthy Participants — clinical trial record (NCT07701083)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-07-20

View on ClinicalTrials.gov ↗

The main purpose of this study is to learn about safety, tolerability and how well the body processes two different eloralintide solutions. Participation in this study will last about 13 weeks, including screening, inpatient treatment, and follow-up.

Amendment history 1 change detected by DataLookout

2026-08-21

Recruitment opened

Trial Details

NCT Number	NCT07701083
Lead Sponsor	Eli Lilly and Company
Conditions	Healthy Volunteers
Enrollment	58 participants
Start Date	2026-07-20
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-20